recreational marijuana

Pennsylvania lawmakers advanced a $50.8 billion spending plan after a week-and-a-half delay, including funding for public education, energy policies, and teacher pensions. The bipartisan budget excludes tax code changes and recreational marijuana, with the governor's proposed funding sources now requiring legislative action due to a court ruling.

Virginia will allow recreational marijuana sales in retail stores starting July 1, 2027, with up to 350 shops permitted under state budget legislation. The law increases possession limits to 2 ounces, allows home cultivation, and imposes taxes expected to generate $51 million in revenue, driven by Democratic lawmakers despite Republican concerns over public safety.

Virginia will allow recreational marijuana sales in retail stores starting July 1, 2027, with up to 350 cannabis shops permitted. The law increases possession limits from 1 to 2 ounces and imposes an excise tax, generating an estimated $51 million in state revenue.

Virginia will begin allowing recreational marijuana sales in retail stores in 2027. The state legalized possession of the drug in 2019 but had not established a retail market until now.

Virginia budget leaders have reached an 'agreement in principle' for a deal, while the state transportation board authorized a $29 billion multiyear improvement plan. Additional headlines include the Department of Justice challenging Virginia laws on officer face coverings and ICE agreements.

The U.S. Department of Justice rescheduled medical marijuana from Schedule I to Schedule III, allowing tax benefits and research opportunities, but recreational cannabis remains Schedule I. States with cannabis programs are awaiting further federal guidance, with some adjusting regulations to align with the new classification while maintaining existing laws.

The U.S. Department of Justice rescheduled medical marijuana from Schedule I to Schedule III, allowing federal tax benefits and research opportunities. However, recreational marijuana remains Schedule I, and states with cannabis programs are awaiting further federal guidance. The DEA plans a hearing on potential de-scheduling of marijuana, but most state programs will likely continue unchanged.

The U.S. Department of Justice rescheduled medical marijuana from Schedule I to III, allowing federal tax benefits and research opportunities, but recreational cannabis remains Schedule I. States with medical or recreational programs await further federal guidance, with some, like Nevada and California, adjusting regulations to align with the rescheduling while maintaining existing state laws.

The U.S. Department of Justice rescheduled medical marijuana from Schedule I to III, enabling tax benefits and research opportunities. However, federal and state marijuana policies remain conflicting, with recreational cannabis still classified as Schedule I. States like Nevada and California are adjusting regulations but await further federal guidance.

The U.S. Department of Justice rescheduled medical marijuana from Schedule I to Schedule III, allowing tax benefits and research opportunities, but recreational marijuana remains Schedule I. States like Nevada and California are adjusting policies but await further federal guidance, as the DEA prepares to review broader marijuana de-scheduling.